CPHA Canvax

"When a COVID-19 vaccine becomes available, it will effectively stop disease transmission only if it reaches the people who need it. Many decisions go into developing a strategy for the delivery of a new vaccine, including planning for distribution challenges, communication around vaccine efficacy and safety, and planning for limitations in production capacity. Experts on epidemiology, policy, and advocacy at the International Vaccine Access Center will engage participants to consider decision-making processes and opportunities for innovation to optimize delivery and impact." - How will a COVID-19 Vaccine be Delivered?

The slides and Q&A document is available in the link below.

Rating See Comments Ratings


Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and Delivery
Program Delivery and Evaluation
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.